Navigation Links
Mirati Therapeutics Reports Third Quarter 2013 Financial Results
Date:11/12/2013

y involve numerous risks and uncertainties, known and unknown, many of which are beyond Mirati's control. Such statements can usually be identified by the use of words such as "may", "would", "believe", "intend", "plan", "anticipate", "estimate" and other similar terminology, or state that certain actions, events or results "may" or "would" be taken, occur or be achieved. Forward-looking statements in this release include, but are not limited to, statements regarding the potential for accelerated approval path for MGCD265, ability to secure a partner for the mocetinostat program, and the ability to obtain an SPA from the FDA.

Whether actual results and developments will conform with our expectations and predictions is subject to a number of risks, assumptions and uncertainties, many of which are beyond our control, and the effects of which can be difficult to predict. These risks include those inherent in drug development, whether Mirati will be able to obtain financing when needed or on favorable terms, and other risks described in Mirati's filings with the Securities and Exchange Commission. In evaluating any forward-looking statements in this release, Mirati cautions readers not to place undue reliance on any forward-looking statements. Unless otherwise required by applicable securities laws, Mirati does not intend, nor does it undertake any obligation, to update or revise any forward-looking statements contained in this news release to reflect subsequent information, events, results or circumstances or otherwise.

 Mirati Therapeutics, Inc.Consolidated Statements of Operations and Comprehensive Loss(In thousands except for share and per share amounts)

(Unaudited)Three months ended September 30,Nine months ended September 30,2013201220132012ExpensesResearch and development, net$

5,492$

4,249$

15,477$

10,105General and administrative3,7101,7178,6164,019Total opera
'/>"/>

SOURCE Mirati Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Mirati Therapeutics Prices Public Offering Of Common Stock
2. Sorrento Therapeutics Adopts Stockholder Rights Plan
3. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
4. Shield Therapeutics Files Investigational New Drug Application for ST10 for the Treatment of Iron Deficiency in Chronic Kidney Disease
5. Cara Therapeutics Files Registration Statement for Proposed Initial Public Offering
6. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
7. Echo Therapeutics Announces Third Quarter 2013 Financial Results
8. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
9. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
10. PDL BioPharma Provides $70 Million in Financing to Durata Therapeutics
11. PTC Therapeutics to Present at Credit Suisse Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... --  Royal Philips (NYSE: PHG ... clearance from the U.S. Food and Drug Administration to ... the U.S. VISIQ is the first Philips ... performance and simplicity into a single miniaturized solution, helping ... OB patients. This breakthrough ultrasound device can ...
(Date:7/24/2014)... 2014  Bruin Biometrics (BBI), a pioneer in ... two weeks of clinical briefings to over 200 ... gained substantial concurrence on both the clinical validity ... of BBI,s SEM Scanner. "From ... respondents drawn from the European Wound Management Association ...
(Date:7/24/2014)... -- As part of its ongoing effort to help women pharmacists ... Ownership Boot Camp on July 26 as part of the ... D.C. The Boot Camp is designed ... own their own pharmacies.  Now in its third year, the ... women pharmacists who dream of owning a pharmacy.   ...
Breaking Medicine Technology:Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 2Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 3Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 4
... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI") and Target ... the signing of expanded strategic technology license and ... now has the right to use PBI,s patented ... their planned entry into the clinical diagnostics testing ...
... 2012  Arthrosurface, Inc. ( www.arthrosurface.com ), the developer ... March, it surpassed $100 Million in cumulative net ... achievement for the Company, its management believes that ... patients seeking alternatives to total joint replacement procedures. ...
Cached Medicine Technology:Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 2Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 3Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 4Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 5Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 6Arthrosurface Hits a $100 Million Milestone 2
(Date:7/24/2014)... July 24, 2014 July 22, ... in sealant and anesthesia reversal products to National ... help save young smiles. The donation of over ... Oraverse® was distributed to America’s ToothFairy Affiliate clinical ... vital oral health services. The America’s ToothFairy Affiliate ...
(Date:7/24/2014)... Recently, Stwd.co.uk, a professional supplier of wedding dresses and special ... new designs of cheap wedding dresses to its ... with big discounts. According to the CEO of the company, ... fashionable items. They are available at low rates, up to ... dress was previously priced at $150, and it is offered ...
(Date:7/24/2014)... NV (PRWEB) July 24, 2014 The ... 9:00 am EDT, An archived recorded version can be ... http://www.stocktraderstalk.com , following the interview. , This ... Division which provides commercial quality, advanced, digital security solutions ... and SOX and their CipherLoc product suite offers both ...
(Date:7/24/2014)... In response to a ... may benefit from parathyroidectomy, Dr. Babak Larian of ... Hills today commented on hyperparathyroidism, a commonly misunderstood ... because its symptoms are vague and similar to ... have been diagnosed with fibromyalgia may actually be ...
(Date:7/24/2014)... San Jose, California (PRWEB) July 24, 2014 ... – Molecular diagnosis represents a rapidly expanding sector ... DNA probes, biochips, specimen collection devices, new detection ... diagnostics high on sensitivity, versatility, and speed. In ... being embraced for its benefits in patient stratification, ...
Breaking Medicine News(10 mins):Health News:Septodont Donation Helps Children in Need 2Health News:Cheap Wedding Dresses Are Offered by Stwd.co.uk at Low Prices 2Health News:Cloud Medical Doctor Software Corporation, CEO, Michael DeLaGarza, Exclusive Interview on StockTradersTalk.com 2Health News:Cloud Medical Doctor Software Corporation, CEO, Michael DeLaGarza, Exclusive Interview on StockTradersTalk.com 3Health News:Is Hyperparathyroidism Misdiagnosed as Fibromyalgia? 2Health News:Is Hyperparathyroidism Misdiagnosed as Fibromyalgia? 3Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 4
... to Sponsor the Congenital Heart Futures Act - ... Disease Registry, Congenital Heart Defect Research and EducationCHICAGO, ... - the country,s leading organization solely dedicated to ... organizations participating in National Congenital Heart Lobby Day ...
... Week for providing "vital information" to viewers, Sharing ... tells the compelling and inspirational stories of real patients -- ... Albany, NY; Austin, TX; Salt Lake City, UT; Portland, OR; ... now airs on nearly 260 television stations across the United ...
... to Improve Your Heart Health Through Proper Oral Care ... women throughout the U.S. will be making personal pledges ... national initiative and promote heart health awareness, WomenHeart has ... campaign. Heart Promises will focus on ...
... Financially Untenable -LOS ANGELES, Feb. 9 According to ... offered for the closing of the Motion Picture and ... raising questions about the underlying reasons for displacing dozens ... out their lives at the facility.The story by TheWrap.Com,s ...
... at risk are encouraged to learn about Heart Failure-how to ... during Heart Failure Awareness Week February 8-14, 2009 Heart ... 11 Fact-Filled Education Modules Available at www.abouthf.org ... Awareness Week is set for February 8-14. This ...
... public relations,agency Waggener Edstrom Worldwide (WE) will ... in the Digital World: Mitigating the Risks,in ... take place on,Tuesday, Feb. 24, 9 a.m. ... and be,available via webcast at, http://waggeneredstrom.com/reg/events/healthcare-webcast.aspx . ...
Cached Medicine News:Health News:The Children's Heart Foundation to Support National Congenital Heart Coalition (NCHC) on Capitol Hill by Participating in National Congenital Heart Lobby Day on February 10 2Health News:The Children's Heart Foundation to Support National Congenital Heart Coalition (NCHC) on Capitol Hill by Participating in National Congenital Heart Lobby Day on February 10 3Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 2Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 3Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 4Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 5Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 6Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 2Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 3Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 4Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 2Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 3Health News:Healthcare Online Regulations Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
The Assistant Free Self-Retaining Hip Surgery Retractor System is used for hip arthroplasty and hip fracture surgery....
The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade....
Low-profile hand-held instruments....
Medicine Products: